Mikael Dolsten - 22 Feb 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role: President R&D
Signature: Susan E. Grant, by power of atty., for Mikael Dolsten
Issuer symbol: PFE
Transactions as of: 22 Feb 2023
Net transactions value: -$1,381,249
Form type: 4
Filing time: 24 Feb 2023, 19:18:31 UTC
Previous filing: 09 Nov 2022
Next filing: 28 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Tax liability	$1,381,249	-32,592	-7.7%	$42.38	391,223	22 Feb 2023	Direct	F1
holding	PFE	Common Stock						1,881	22 Feb 2023	By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+137,760		$0.000000	137,760	23 Feb 2023	Common Stock	137,760	$42.30	Direct	F2
transaction	PFE	Stock Appreciation Rights	Award	$0	+119,894		$0.000000	119,894	23 Feb 2023	Common Stock	119,894	$42.30	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.